drugset / Trial / NCT01124981
Haemocomplettan® P During Elective Complex Cardiac Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Fibrinogen concentrate is increasingly used in cardiac surgery to reverse coagulopathy. Whether its use reduces blood loss, transfusion and occurrence of clinical adverse events remains unknown.
Timeline
- Start
- 2011-02
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fibrinogen Concentrate Human | Protein / enzyme biologic | — | Intravenous |